Jeremy Davis
Title
Cited by
Cited by
Year
Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
PD Davis, DFC Moffat, JM Davis, MC Hutchings
US Patent 5,958,935, 1999
2261999
Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
PD Davis, DFC Moffat, JM Davis, MC Hutchings
US Patent 6,235,746, 2001
1922001
5-cyano-2-aminopyrimidine derivatives
MJ Batchelor, DFC Moffat, JM Davis, MC Hutchings
US Patent 6,579,983, 2003
1692003
Modulators of 14-3-3 protein–protein interactions
LM Stevers, E Sijbesma, M Botta, C MacKintosh, T Obsil, I Landrieu, ...
Journal of medicinal chemistry 61 (9), 3755-3778, 2017
1222017
Stabilization of protein-protein interactions in drug discovery
SA Andrei, E Sijbesma, M Hann, J Davis, G O’Mahony, MWD Perry, ...
Expert Opinion on Drug Discovery 12 (9), 925-940, 2017
932017
Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors
J Porter, A Payne, B de Candole, D Ford, B Hutchinson, G Trevitt, J Turner, ...
Bioorganic & medicinal chemistry letters 19 (1), 230-233, 2009
892009
Formation of zirconocene η2-imine complexes by rearrangement of cyclic iminoacyl complexes.
JM Davis, RJ Whitby, A Jaxa-Chamiec
Tetrahedron letters 33 (38), 5655-5658, 1992
781992
c-Jun N-terminal kinase primes endothelial cells at atheroprone sites for apoptosis
H Chaudhury, M Zakkar, J Boyle, S Cuhlmann, K van der Heiden, ...
Arteriosclerosis, thrombosis, and vascular biology 30 (3), 546-553, 2010
682010
4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: Synthesis and biological evaluation
TV Hughes, SL Emanuel, AK Beck, SK Wetter, PJ Connolly, P Karnachi, ...
Bioorganic & medicinal chemistry letters 17 (12), 3266-3270, 2007
502007
4, 5-disubstituted-2-aminopyrimidines
JM Davis, DFC Moffat
US Patent 6,600,037, 2003
432003
Fused polycyclic 2-aminopyrimidine derivatives
JM Davis, PD Davis, DFC Moffat, MJ Batchelor
US Patent 6,057,329, 2000
392000
Atropisomeric small molecule Bcl-2 ligands: determination of bioactive conformation
J Porter, A Payne, I Whitcombe, B de Candole, D Ford, R Garlish, A Hold, ...
Bioorganic & medicinal chemistry letters 19 (6), 1767-1772, 2009
382009
Pyridine and pyrimidine derivatives
JM Davis, BJ Langham, M Naik, DC Brookings, RJ Cubbon, RJ Franklin
US Patent 7,323,464, 2008
372008
Synthesis of cyclopentylamines using zirconium chemistry
JM Davis, RJ Whitby, A Jaxa-Chamiec
Tetrahedron letters 35 (9), 1445-1448, 1994
371994
5-aminopyrazoles useful as tyrosine kinase inhibitors
PD Davis, JM Davis, DFC Moffat
US Patent 5,922,741, 1999
361999
Fused polycyclic 2-aminopyrimidine derivatives
JM Davis, PD Davis, DFC Moffat, MJ Batchelor
US Patent 6,599,908, 2003
322003
Bicyclic oxopyridine and oxopyrimidine derivatives
JM Davis, DC Brookings, BJ Langham
US Patent 7,176,215, 2007
232007
Synthesis and biological study of 2-amino-4-aryl-5-chloropyrimidine analogues as inhibitors of VEGFR-2 and cyclin dependent kinase 1 (CDK1)
S Huang, R Li, PJ Connolly, S Emanuel, A Fuentes-Pesquera, M Adams, ...
Bioorganic & medicinal chemistry letters 17 (8), 2179-2183, 2007
192007
Scalable Synthesis of the VEGF-R2 Kinase Inhibitor JNJ-17029259 Using Ultrasound-Mediated Addition of MeLi−CeCl3 to a Nitrile
M Reuman, S Beish, J Davis, MJ Batchelor, MC Hutchings, DFC Moffat, ...
The Journal of organic chemistry 73 (3), 1121-1123, 2008
182008
5-Cyano-2-aminopyrimidine derivatives
M Batchelor, DC Moffat, J Davis, M Hutchings
US Patent App. 10/812,293, 2004
182004
The system can't perform the operation now. Try again later.
Articles 1–20